Pathophysiology and Clinical Profile
Definition and Pathophysiology
- Rare, dramatic, acute presentation of celiac disease.
- Occurs predominantly in young children prior to formal diagnosis.
- Autoimmune enteropathy triggered by gluten ingestion in genetically susceptible individuals expressing HLA-DQ2/DQ8 haplotypes.
- T-cell-mediated chronic inflammatory response.
- Intestinal villous atrophy decreases absorptive surface, causing severe malabsorption.
- Sudden exacerbation precipitates massive secretory and osmotic fluid losses.
Clinical Features
| Category | Manifestations |
|---|
| Gastrointestinal | Explosive diarrhea. |
| Metabolic | Profound electrolyte abnormalities, metabolic acidosis. |
| Hemodynamic | Severe dehydration, lethargy, potential hypovolemic shock. |
| Nutritional | Protein-losing enteropathy, profound hypoalbuminemia, severe malnutrition, cachexia. |
Diagnostic Evaluation
Laboratory Investigations
- Serum electrolytes: Detect profound derangements, confirm metabolic acidosis.
- Complete blood count: Identify associated anemia, predominantly iron-deficient.
- Hepatic panel: Evaluate secondary hypertransaminasemia, assess serum albumin for protein-losing enteropathy.
- Celiac serology: Assess tissue transglutaminase (tTG) IgA and endomysial antibodies (EMA) IgA.
Histopathology
- Esophagogastroduodenoscopy with biopsy: Required for definitive diagnosis after initial stabilization.
- Target biopsy sites: Minimum four biopsies from distal duodenum, one from duodenal bulb.
- Characteristic findings: Villous atrophy, crypt hyperplasia, intraepithelial lymphocytosis.
Management Protocol
Acute Resuscitation and Stabilization
Fluid and Electrolyte Correction
- Intravenous fluid resuscitation: Mandatory intervention for severe dehydration and explosive diarrhea.
- Electrolyte replacement: Urgent correction of profound deficits.
- Acid-base management: Intravenous bicarbonate administration for severe metabolic acidosis.
Oncotic Support
- Intravenous albumin infusion: Indicated for symptomatic hypoalbuminemia secondary to protein-losing enteropathy.
Definitive Dietary Therapy
Gluten Elimination
- Lifelong, strict adherence to gluten-free diet.
- Complete elimination: Wheat, rye, barley, related derivatives (triticale, spelt, kamut, malt).
- Safe grain alternatives: Rice, corn, buckwheat, millet, amaranth, quinoa.
- Threshold limits: Daily gluten intake strictly maintained below 10 mg.
- Professional consultation: Mandatory skilled dietician involvement for counseling and compliance monitoring.
Nutritional Rehabilitation
Micronutrient and Macronutrient Supplementation
- Iron therapy: 2-5 mg/kg elemental iron for deficiency anemia correction.
- Vitamin supplementation: Fat-soluble vitamins (A, D, E, K) for malabsorption.
- Bone health: Calcium and vitamin D supplementation to reverse osteopenia/osteoporosis.
- Pancreatic enzyme supplementation: Temporary administration for secondary pancreatic hypofunction facilitating weight gain.
Advanced Pharmacotherapy
- Corticosteroids: Short course indicated for severe, refractory enteropathy or associated multiple nonpeptic duodenal ulcers.
- Immunosuppressants: Azathioprine, 6-mercaptopurine, or cyclosporine reserved for nonresponsive or refractory celiac disease failing strict dietary elimination.
Long-Term Monitoring
Surveillance Parameters
- Clinical response: Track resolution of diarrhea, monitor weight velocity and linear growth.
- Serologic monitoring: Serial measurement of tTG IgA levels at 6 months, then annually to confirm dietary compliance.
- Comorbidity screening: Evaluate for associated autoimmune conditions including type 1 diabetes, autoimmune thyroiditis, and selective IgA deficiency.